Expedient Synthesis of MLN1251, A CCR5 Antagonist for Treatment of HIV
Authors:
- 18 January 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 11 (2) , 241-245
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Orally Bioavailable Competitive CCR5 AntagonistsJournal of Medicinal Chemistry, 2004
- Antiretroviral Therapy for HIV Infection in 1998JAMA, 1998
- HIV-1 Protease InhibitorsJAMA, 1997
- CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1Science, 1996
- HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5Nature, 1996
- Identification of a major co-receptor for primary isolates of HIV-1Nature, 1996
- HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled ReceptorScience, 1996
- Azapropellanes as phase-transfer catalysts. I. Introduction and synthesis of (±)1-azoniatricyclo[4.4.4.01,6]tetradecane and(±)1-azoniatricyclo[4.4.3.01,6]tridecane saltsCanadian Journal of Chemistry, 1980